To qualify as a Health Deal, the intended innovation – whether it is a technological or a social innovation or combination – must have a clear benefit for the patient and save costs. For patients, this means a health benefit or an improvement in their quality of life or the control over their lives. It is also vital that the innovation results in existing, outdated applications no longer being used. After all, innovations are only cost effective once they fully replace something and are not merely added to existing options.
Another condition is that users and patients be clearly involved in the development: in collaboration with industry, the initiative must lie with them and therefore the approach must be bottom up. The government can subsequently encourage the development, for example by solving bottlenecks in legislation and by reducing the administrative burden.